Healthcare
Live Price
Offline$4.32
+0.47% today
1Y Change
+80.15%
Window
Jun 27, 2025 → Jun 18, 2026
Coverage: 245 bars · Jun 27, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kalaris Therapeutics Inc (KLRS) is a Healthcare stock with a market cap of $100.00M and listed on NASDAQ. The stock last traded around $4.32 and up 80.2% across the available one-year price window (Jun 27, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +75.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +75.7%, free cash flow +36.2% with operating margin 0.0% and ROIC -41.1%. Stock Foundry combines KLRS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KLRS
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KLRS Max Drawdown
-62.80%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for KLRS and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.